Paka Pulmonary Pharmaceuticals Inc is categorized under Commercial Medical Research in Acton, MA and active since 2008.
Paka Pulmonary Pharmaceuticals Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Lee Brettman at the company’s single location by writing to 24 Liberty St, Acton, Massachusetts MA 01720 or by phoning (978) 263-3051. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Paka Pulmonary Pharmaceuticals Inc |
Contact Person: | Lee Brettman |
Address: | 24 Liberty St, Acton, Massachusetts 01720 |
Phone Number: | (978) 263-3051 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Paka Pulmonary Pharmaceuticals Inc was started in 2008 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Lee Brettman for inquiries that concern Paka Pulmonary Pharmaceuticals Inc by calling the company number (978) 263-3051, as your correspondence is most welcome. Additionally, the physical location of the single location of Paka Pulmonary Pharmaceuticals Inc can be found at the coordinates 42.455891,-71.461948 as well as the street address 24 Liberty St in Acton, Massachusetts 01720.
For its online presence, you may visit Paka Pulmonary Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.